Published in Alzheimer Dis Assoc Disord on January 10, 2000
Exploring the effects of coexisting amyloid in subcortical vascular cognitive impairment. BMC Neurol (2015) 1.38
Low dose aspirin and cognitive function in the women's health study cognitive cohort. BMJ (2007) 1.34
Role of vascular risk factors and vascular dysfunction in Alzheimer's disease. Mt Sinai J Med (2010) 1.28
Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size. Stroke (2010) 1.16
Subcortical vascular dementia: integrating neuropsychological and neuroradiologic data. Neurology (2005) 1.14
Cognitive profile of chronic kidney disease and hemodialysis patients without dementia. Nephron Clin Pract (2010) 1.01
Rivastigmine in the treatment of Alzheimer's disease: an update. Clin Interv Aging (2007) 0.97
Vascular dementia: prevention and treatment. Clin Interv Aging (2006) 0.87
Selective neuronal damage and Wisconsin Card Sorting Test performance in atherosclerotic occlusive disease of the major cerebral artery. J Neurol Neurosurg Psychiatry (2010) 0.85
Longitudinal assessment of cognitive function by clock drawing in older adults. Dement Geriatr Cogn Dis Extra (2011) 0.77
Upper-Extremity Dual-Task Function: An Innovative Method to Assess Cognitive Impairment in Older Adults. Front Aging Neurosci (2016) 0.75
Effects of combined fine motor skill and cognitive therapy to cognition, degree of dementia, depression, and activities of daily living in the elderly with Alzheimer's disease. J Phys Ther Sci (2015) 0.75
Assessment of free and cued recall in Alzheimer's disease and vascular and frontotemporal dementia with 24-item Grober and Buschke test. Neurol Sci (2016) 0.75
Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci (1998) 2.28
Relationship between white matter fractional anisotropy and other indices of cerebral health in normal aging: tract-based spatial statistics study of aging. Neuroimage (2006) 2.09
Loss of cerebral white matter structural integrity tracks the gray matter metabolic decline in normal aging. Neuroimage (2008) 1.18
Risk factors for the onset of depression in middle age and later life. Soc Psychiatry Psychiatr Epidemiol (1993) 1.04
Comments on the executive control of clock-drawing. J Am Geriatr Soc (1996) 0.90
The use of herbal alternative medicines in neuropsychiatry. A report of the ANPA Committee on Research. J Neuropsychiatry Clin Neurosci (2000) 0.86
EXIT, QED, and DSM-IV: very early Alzheimer's disease. J Neuropsychiatry Clin Neurosci (1994) 0.86
Qualitative assessment of dementia. J Am Geriatr Soc (1994) 0.84
A historical review of the concept of vascular dementia: lessons from the past for the future. Alzheimer Dis Assoc Disord (2000) 0.81
The FAB: a frontal assessment battery at bedside. Neurology (2001) 0.77
EXIT, QED, and DSM-IV: regional syndromes. J Neuropsychiatry Clin Neurosci (1994) 0.75
[On "Proposal for the application and scoring of the clock drawing test in Alzheimer's disease"]. Rev Neurol (2000) 0.75
ECF deficits and anorectic behavior. J Am Geriatr Soc (1991) 0.75
Validating the GDS in a nursing home sample. J Am Geriatr Soc (1996) 0.75
Some "depressive" symptoms may not imply depression. J Am Geriatr Soc (1997) 0.75
Differentiation of vascular dementia from AD on neuropsychological tests. Neurology (2000) 0.75
Pharmacologic efficacy in neuropsychiatry: a review of placebo-controlled treatment trials. A report of the ANPA Committee on Research. J Neuropsychiatry Clin Neurosci (1999) 0.75
Dopaminergic mediation of reward: evidence gained using a natural reinforcer in a behavioral contrast paradigm. Neurosci Lett (1981) 0.75
The clinician-scientist in neuropsychiatry: a position statement from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci (1998) 0.75
Assessment of treatment outcomes in neuropsychiatry: a report from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci (1995) 0.75